SPTX
Seaport Therapeutics, Inc.Company with tickers: SPTX
CIK
2042347
CUSIP
81221K108
Shares Outstanding
53,027,817
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-04 | Chen Michael Cunyuan |
Chief Scientific Officer | Other | 10,526 |
| 2026-05-04 | PureTech Health plc |
10% Owner | Other | 965,255 |
| 2026-05-04 | PureTech Health plc |
10% Owner | Other | 2,681,265 |
| 2026-05-04 | Torres Denice |
Director | Other | 13,406 |
| 2026-05-04 | PureTech Health plc |
10% Owner | Other | 12,736,014 |
| 2026-05-04 | PAUL STEVEN M |
Director | Other | 67,031 |
| 2026-05-04 | Chen Michael Cunyuan |
Chief Scientific Officer | Other | 3,351 |
| 2026-05-04 | General Atlantic (SP), L.P. |
Director, 10% Owner | Other | 6,101,582 |
| 2026-05-04 | PureTech Health plc |
10% Owner | Other | 3,031,578 |
| 2026-05-04 | Gladstein Lana |
General Counsel | Other | 33,515 |
| 2026-05-04 | ARCH Venture Partners XII, LLC |
10% Owner | Other | 2,681,265 |
| 2026-05-04 | HEALY JAMES |
Director | Other | 6,052,631 |
| 2026-05-04 | HEALY JAMES |
Director | Other | 804,379 |
| 2026-05-04 | PureTech Health plc |
10% Owner | Other | 40,000,000 |
| 2026-05-04 | White Lauren |
Chief Financial Officer | Other | 6,702 |
| 2026-05-04 | HEALY JAMES |
Director | Other | 1,927,159 |
| 2026-05-04 | GAP Coinvestments CDA, L.P. |
Director, 10% Owner | Other | 6,101,582 |
| 2026-05-04 | HEALY JAMES |
Director | Other | 2,526,315 |
| 2026-05-04 | ARCH Venture Partners XII, LLC |
10% Owner | Other | 2,513,686 |
| 2026-05-04 | PAUL STEVEN M |
Director | Other | 210,526 |
| 2026-05-04 | PureTech Health plc |
10% Owner | Other | 8,421,052 |
| 2026-05-04 | Torres Denice |
Director | Other | 42,105 |
| 2026-05-04 | ARCH Venture Partners XII, LLC |
10% Owner | Other | 2,681,265 |
| 2026-05-04 | ARCH Venture Partners XII, LLC |
10% Owner | Buy | 1,100,000 |
| 2026-05-04 | White Lauren |
Chief Financial Officer | Other | 21,052 |
| 2026-05-04 | ARCH Venture Partners XII, LLC |
10% Owner | Other | 2,513,686 |
| 2026-05-04 | Loebel Antony |
Director | Other | 20,109 |
| 2026-05-04 | Gladstein Lana |
General Counsel | Other | 105,263 |
| 2026-05-04 | Loebel Antony |
Director | Other | 63,157 |
| 2026-04-30 | HEALY JAMES |
Director | Other | 0 |
| 2026-04-30 | White Lauren |
Chief Financial Officer | Other | 0 |
| 2026-04-30 | PureTech Health plc |
10% Owner | Other | 302,479 |
| 2026-04-30 | White Lauren |
Chief Financial Officer | Other | 0 |
| 2026-04-30 | Zohar Daphne |
Director, Chief Executive Officer | Award | 1,486,786 |
| 2026-04-30 | Chen Michael Cunyuan |
Chief Scientific Officer | Other | 0 |
| 2026-04-30 | Mates Sharon |
Director | Award | 49,033 |
| 2026-04-30 | PETERSON SANDRA E |
Director | Other | 0 |
| 2026-04-30 | Gladstein Lana |
General Counsel | Other | 0 |
| 2026-04-30 | PureTech Health plc |
10% Owner | Other | 0 |
| 2026-04-30 | PAUL STEVEN M |
Director | Other | 0 |
| 2026-04-30 | Loebel Antony |
Director | Other | 0 |
| 2026-04-30 | Torres Denice |
Director | Award | 12,258 |
| 2026-04-30 | PAUL STEVEN M |
Director | Other | 0 |
| 2026-04-30 | ARCH Venture Partners XII, LLC |
10% Owner | Other | 0 |
| 2026-04-30 | Wheadon David E. |
Director | Other | 0 |
| 2026-04-30 | Zohar Daphne |
Director, Chief Executive Officer | Other | 0 |
| 2026-04-30 | Pitts Jason |
Director | Other | 0 |
| 2026-04-30 | PETERSON SANDRA E |
Director | Award | 12,258 |
| 2026-04-30 | Wheadon David E. |
Director | Award | 12,258 |
| 2026-04-30 | White Lauren |
Chief Financial Officer | Award | 63,680 |
Showing 1–50 of 87 transactions